150 related articles for article (PubMed ID: 37119001)
21. Screening and interventions to prevent nonalcoholic fatty liver disease/nonalcoholic steatohepatitis-associated hepatocellular carcinoma.
Cernea S; Onișor D
World J Gastroenterol; 2023 Jan; 29(2):286-309. PubMed ID: 36687124
[TBL] [Abstract][Full Text] [Related]
22. Diagnosis of hepatic nodules 20 mm or smaller in cirrhosis: Prospective validation of the noninvasive diagnostic criteria for hepatocellular carcinoma.
Forner A; Vilana R; Ayuso C; Bianchi L; Solé M; Ayuso JR; Boix L; Sala M; Varela M; Llovet JM; Brú C; Bruix J
Hepatology; 2008 Jan; 47(1):97-104. PubMed ID: 18069697
[TBL] [Abstract][Full Text] [Related]
23. Hyperlipidemia and Nonalcoholic Steatohepatitis Predispose to Hepatocellular Carcinoma Development Without Cirrhosis.
Phan J; Ng V; Sheinbaum A; French S; Choi G; El Kabany M; Durazo F; Saab S; Tong M; Busuttil R; Han SH
J Clin Gastroenterol; 2019 Apr; 53(4):309-313. PubMed ID: 29912756
[TBL] [Abstract][Full Text] [Related]
24. The incidence and risk factors of hepatocellular carcinoma in patients with nonalcoholic steatohepatitis.
Ascha MS; Hanouneh IA; Lopez R; Tamimi TA; Feldstein AF; Zein NN
Hepatology; 2010 Jun; 51(6):1972-8. PubMed ID: 20209604
[TBL] [Abstract][Full Text] [Related]
25. Hepatic neoplasia: selected clinical aspects.
Schiff L
Semin Roentgenol; 1983 Apr; 18(2):71-4. PubMed ID: 6191395
[TBL] [Abstract][Full Text] [Related]
26. Hepatocellular carcinoma in cirrhosis: incidence and risk factors.
Fattovich G; Stroffolini T; Zagni I; Donato F
Gastroenterology; 2004 Nov; 127(5 Suppl 1):S35-50. PubMed ID: 15508101
[TBL] [Abstract][Full Text] [Related]
27. [Hepatocellular carcinoma in the non-cirrhotic liver].
Evert M; Dombrowski F
Pathologe; 2008 Feb; 29(1):47-52. PubMed ID: 18057936
[TBL] [Abstract][Full Text] [Related]
28. Etiologic factors and clinical presentation of hepatocellular carcinoma. Differences between cirrhotic and noncirrhotic Italian patients.
Trevisani F; D'Intino PE; Caraceni P; Pizzo M; Stefanini GF; Mazziotti A; Grazi GL; Gozzetti G; Gasbarrini G; Bernardi M
Cancer; 1995 May; 75(9):2220-32. PubMed ID: 7536121
[TBL] [Abstract][Full Text] [Related]
29. From diagnosis to treatment of hepatocellular carcinoma: An epidemic problem for both developed and developing world.
Dimitroulis D; Damaskos C; Valsami S; Davakis S; Garmpis N; Spartalis E; Athanasiou A; Moris D; Sakellariou S; Kykalos S; Tsourouflis G; Garmpi A; Delladetsima I; Kontzoglou K; Kouraklis G
World J Gastroenterol; 2017 Aug; 23(29):5282-5294. PubMed ID: 28839428
[TBL] [Abstract][Full Text] [Related]
30. Risk of development of hepatocellular carcinoma in patients with NASH-related cirrhosis.
Amarapurkar DN; Dharod M; Gautam S; Patel N
Trop Gastroenterol; 2013; 34(3):159-63. PubMed ID: 24851525
[TBL] [Abstract][Full Text] [Related]
31. Hepatocellular carcinoma in non-alcohol fatty liver disease - changing trends and specific challenges.
Berkan-Kawińska A; Piekarska A
Curr Med Res Opin; 2020 Feb; 36(2):235-243. PubMed ID: 31631714
[No Abstract] [Full Text] [Related]
32. Risk lesions in cirrhosis and development of hepatocellular carcinoma: an autopsy study.
Nakanuma Y; Kanel GC; Doishita K; Ohta G; Peters RL
Biomed Pharmacother; 1989; 43(2):127-33. PubMed ID: 2544232
[TBL] [Abstract][Full Text] [Related]
33. Non-alcoholic fatty liver disease associated with hepatocellular carcinoma: An increasing concern.
Dhamija E; Paul SB; Kedia S
Indian J Med Res; 2019 Jan; 149(1):9-17. PubMed ID: 31115369
[TBL] [Abstract][Full Text] [Related]
34. Does hepatocellular carcinoma in non-alcoholic steatohepatitis exist in cirrhotic and non-cirrhotic patients?
Chagas AL; Kikuchi LO; Oliveira CP; Vezozzo DC; Mello ES; Oliveira AC; Cella LC; Herman P; Bachella T; Caldwell SH; Alves VA; Carrilho FJ
Braz J Med Biol Res; 2009 Oct; 42(10):958-62. PubMed ID: 19787150
[TBL] [Abstract][Full Text] [Related]
35. Hepatitis B virus, hepatocellular carcinoma and liver cirrhosis in Kenya.
Mwangi J; Gatei DG
East Afr Med J; 1993 Apr; 70(4 Suppl):34-6. PubMed ID: 8223308
[TBL] [Abstract][Full Text] [Related]
36. The Gut Microbiome and Hepatocellular Carcinoma.
Akkız H
J Gastrointest Cancer; 2021 Dec; 52(4):1314-1319. PubMed ID: 34870783
[TBL] [Abstract][Full Text] [Related]
37. Incidence of hepatocellular carcinoma among Indian patients with cirrhosis of liver: an experience from a tertiary care center in northern India.
Paul SB; Sreenivas V; Gulati MS; Madan K; Gupta AK; Mukhopadhyay S; Panda SK; Acharya SK
Indian J Gastroenterol; 2007; 26(6):274-8. PubMed ID: 18431010
[TBL] [Abstract][Full Text] [Related]
38. Risk and outcome of hepatocellular carcinoma in liver cirrhosis in Southern Sweden: a population-based study.
Nilsson E; Anderson H; Sargenti K; Lindgren S; Prytz H
Scand J Gastroenterol; 2019 Aug; 54(8):1027-1032. PubMed ID: 31389730
[No Abstract] [Full Text] [Related]
39. Characterization of hepatocellular carcinoma (HCC) in non-alcoholic fatty liver disease (NAFLD) patients without cirrhosis.
Mohamad B; Shah V; Onyshchenko M; Elshamy M; Aucejo F; Lopez R; Hanouneh IA; Alhaddad R; Alkhouri N
Hepatol Int; 2016 Jul; 10(4):632-9. PubMed ID: 26558795
[TBL] [Abstract][Full Text] [Related]
40. Fibrosis Severity as a Determinant of Cause-Specific Mortality in Patients With Advanced Nonalcoholic Fatty Liver Disease: A Multi-National Cohort Study.
Vilar-Gomez E; Calzadilla-Bertot L; Wai-Sun Wong V; Castellanos M; Aller-de la Fuente R; Metwally M; Eslam M; Gonzalez-Fabian L; Alvarez-Quiñones Sanz M; Conde-Martin AF; De Boer B; McLeod D; Hung Chan AW; Chalasani N; George J; Adams LA; Romero-Gomez M
Gastroenterology; 2018 Aug; 155(2):443-457.e17. PubMed ID: 29733831
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
